• Exchange: Tel Aviv
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

BioLine RX Ltd

+ Add to Watchlist

BLRX:IT

66.30 ILs 0.20 0.30%

As of 07:12:30 ET on 12/22/2014.

Snapshot for BioLine RX Ltd (BLRX)

Open: 66.30 Day's Range: 65.00 - 68.00 Volume: 875,473
Previous Close: 66.50 52wk Range: 46.80 - 111.00 1-Yr Rtn: -33.83%

Stock Chart for BLRX

No chart data available.
  • BLRX:IT 66.30
  • 1D
  • 1M
  • 1Y
66.50
Interactive BLRX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for BLRX

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. TA-100 -
Earnings Per Share (ILS) (ttm) -0.1400
Est. EPS (ILS) (12/2014) -0.1320
Est. PEG Ratio -
Market Cap (M ILS) 228.23
Shares Outstanding (M) 341.15
30 Day Average Volume 2,308,647
Price/Book (mrq) 2.2844
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 03/17/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for BLRX

  • Revenue
  • Net Income (M/ILS)
  • Profit Margin (%)

Company Profile & Key Executives for BLRX

BioLineRx Ltd. is a biopharmaceutical development company. The Company develops clinical-stage therapeutic pharmaceutical drugs.

Kinneret Livnat SavitskyChief Executive OfficerPhilip SerlinCFO/COO
David MalekVP:Business DevelopmentArnon AharonVP:Medical Affairs
More Company Profile & Key Executives for BLRX

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil